Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Alamar Biosciences is at the forefront of precision proteomics, enabling the earliest detection of diseases through innovative technologies. Their NULISA platform allows researchers to profile thousands of protein biomarkers from minimal fluid samples, enhancing the understanding of the human proteome.
Claim this profile to keep your information accurate and add what's missing.
Not in this profile yet:
A precision proteomics platform that enables the detection and profiling of thousands of protein biomarkers from a single fluid sample with unparalleled sensitivity.
A high-throughput system designed for proteomics analysis, allowing researchers to conduct assays efficiently and effectively.
NULISA technology is a precision proteomics platform that allows for the detection and profiling of thousands of protein biomarkers from minimal fluid samples with high sensitivity.
Researchers from academic institutions, core labs, biopharmaceutical, and biotech companies can benefit from Alamar's innovative proteomics solutions.
Alamar Biosciences is located in Fremont, California, in the heart of Silicon Valley.
Alamar Biosciences focuses on diseases that can be detected through biomarkers, including neurodegenerative diseases like Alzheimer's.
The mission of Alamar Biosciences is to power precision proteomics to enable the earliest detection of disease.